these - Université de Franche-Comté

34 Ainsworth SB, Milligan DW.
Surfactant therapy for respiratory distress syndrome in premature neonates: a
comparative review.
Am J Respir Med. 2002;1(6):417-33.
35 Hallman M.
Lung surfactant phospholipids in the fœtus, newborn, and in the adult;evidence of
abnormality in respiratory failure.
Ann Chir Gynaecol Supll. 1982;196:19-23.
36 Robertson B, Halliday HL.
Principles of surfactant replacement.
Biochim Biophys Acta. 1998 Nov 19;1408(2-3):346-61.
37 Greenough A. Department of Child Health, King's College, London.
Replacement surfactant therapy.
Prof Care Mother Child. 1997;7(4):99-100.
38 Mugford M, Howard S.
Cost effectiveness of surfactant replacement in preterm babies.
Pharmacoeconomics. 1993 May;3(5):362-73.
39 Lachmann B. Department of Anesthesiology, Erasmus University, Rotterdam, The
Netherlands.
Animal studies of surfactant replacement therapy.
Dev Pharmacol Ther. 1989;13(2-4):164-72.
40 Awasthi S, Coalson JJ, Yoder BA, Crouch E, King RJ.
Deficiencies in lung surfactant proteins A and D are associated with lung infection in
very premature neonatal baboons.
Am J Respir Crit Care Med. 2001 Feb;163(2):389-97.
140